• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

遗传疾病与婴儿和幼儿期的死亡率:诊断延误与错失时机。

Genetic disorders and mortality in infancy and early childhood: delayed diagnoses and missed opportunities.

机构信息

Division of Newborn Medicine, Harvard Medical School, Boston, Massachusetts, USA.

Division of Genetics and Genomics, Harvard Medical School, Boston, Massachusetts, USA.

出版信息

Genet Med. 2018 Nov;20(11):1396-1404. doi: 10.1038/gim.2018.17. Epub 2018 Apr 12.

DOI:10.1038/gim.2018.17
PMID:29790870
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6185816/
Abstract

PURPOSE

Infants admitted to a level IV neonatal intensive care unit (NICU) who do not survive early childhood are a population that is probably enriched for rare genetic disease; we therefore characterized their genetic diagnostic evaluation.

METHODS

This is a retrospective analysis of infants admitted to our NICU between 1 January 2011 and 31 December 2015 who were deceased at the time of records review, with age at death less than 5 years.

RESULTS

A total of 2,670 infants were admitted; 170 later died. One hundred six of 170 (62%) had an evaluation for a genetic or metabolic disorder. Forty-seven of 170 (28%) had laboratory-confirmed genetic diagnoses, although 14/47 (30%) diagnoses were made postmortem. Infants evaluated for a genetic disorder spent more time in the NICU (median 13.5 vs. 5.0 days; p = 0.003), were older at death (median 92.0 vs. 17.5 days; p < 0.001), and had similarly high rates of redirection of care (86% vs. 79%; p = 0.28).

CONCLUSION

Genetic disorders were suspected in many infants but found in a minority. Approximately one-third of diagnosed infants died before a laboratory-confirmed genetic diagnosis was made. This highlights the need to improve genetic diagnostic evaluation in the NICU, particularly to support end-of-life decision making.

摘要

目的

住进四级新生儿重症监护病房(NICU)但未能存活至幼儿期的婴儿,其人群可能存在丰富的罕见遗传病;因此,我们对其进行了遗传诊断评估。

方法

这是对 2011 年 1 月 1 日至 2015 年 12 月 31 日期间入住我们 NICU 的婴儿进行的回顾性分析,这些婴儿在记录审查时已经死亡,死亡时的年龄小于 5 岁。

结果

共有 2670 名婴儿被收治;其中 170 名后来死亡。在 170 名死亡婴儿中,有 106 名接受了遗传或代谢障碍的评估。在 170 名死亡婴儿中,有 47 名(28%)被确诊为遗传性疾病,尽管有 14/47(30%)的诊断是在死后做出的。接受遗传疾病评估的婴儿在 NICU 中停留的时间更长(中位数 13.5 天 vs. 5.0 天;p=0.003),死亡时的年龄更大(中位数 92.0 天 vs. 17.5 天;p<0.001),但同样高的转归率(86% vs. 79%;p=0.28)。

结论

许多婴儿被怀疑患有遗传疾病,但只有少数被确诊。约三分之一被诊断出患有遗传疾病的婴儿在获得实验室确认的遗传诊断之前死亡。这凸显了在 NICU 中改进遗传诊断评估的必要性,特别是为了支持临终决策。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8566/6185816/c4ea7ac35c5a/nihms936957f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8566/6185816/6f40a7aef492/nihms936957f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8566/6185816/c4ea7ac35c5a/nihms936957f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8566/6185816/6f40a7aef492/nihms936957f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8566/6185816/c4ea7ac35c5a/nihms936957f2.jpg

相似文献

1
Genetic disorders and mortality in infancy and early childhood: delayed diagnoses and missed opportunities.遗传疾病与婴儿和幼儿期的死亡率:诊断延误与错失时机。
Genet Med. 2018 Nov;20(11):1396-1404. doi: 10.1038/gim.2018.17. Epub 2018 Apr 12.
2
Making a Genetic Diagnosis in a Level IV Neonatal Intensive Care Unit Population: Who, When, How, and at What Cost?在四级新生儿重症监护病房人群中进行基因诊断:谁、何时、如何以及成本如何?
J Pediatr. 2019 Oct;213:211-217.e4. doi: 10.1016/j.jpeds.2019.05.054. Epub 2019 Jun 27.
3
First year mortality and hospital morbidity after newborn intensive care.新生儿重症监护后的第一年死亡率和医院发病率。
N Z Med J. 1987 Sep 9;100(831):548-52.
4
Infant mortality: the contribution of genetic disorders.婴儿死亡率:遗传疾病的贡献。
J Perinatol. 2019 Dec;39(12):1611-1619. doi: 10.1038/s41372-019-0451-5. Epub 2019 Aug 8.
5
Serial assessment of mortality in the neonatal intensive care unit by algorithm and intuition: certainty, uncertainty, and informed consent.通过算法和直觉对新生儿重症监护病房死亡率进行连续评估:确定性、不确定性与知情同意
Pediatrics. 2002 May;109(5):878-86. doi: 10.1542/peds.109.5.878.
6
Congenital anomalies and genetic disorders in neonates and infants: a single-center observational cohort study.新生儿和婴儿的先天性异常和遗传疾病:一项单中心观察性队列研究。
Eur J Pediatr. 2022 Jan;181(1):359-367. doi: 10.1007/s00431-021-04213-w. Epub 2021 Aug 4.
7
Birth weight-specific mortality for extremely low birth weight infants vanishes by four days of life: epidemiology and ethics in the neonatal intensive care unit.极低出生体重儿按出生体重计算的死亡率在出生后四天内消失:新生儿重症监护病房的流行病学与伦理学
Pediatrics. 1996 May;97(5):636-43.
8
Use of Exome Sequencing for Infants in Intensive Care Units: Ascertainment of Severe Single-Gene Disorders and Effect on Medical Management.在重症监护病房对婴儿使用外显子组测序:严重单基因疾病的确诊及对医疗管理的影响
JAMA Pediatr. 2017 Dec 4;171(12):e173438. doi: 10.1001/jamapediatrics.2017.3438.
9
Whole-genome sequencing for identification of Mendelian disorders in critically ill infants: a retrospective analysis of diagnostic and clinical findings.全基因组测序在危重症婴儿孟德尔遗传病诊断中的应用:一项回顾性诊断和临床发现分析。
Lancet Respir Med. 2015 May;3(5):377-87. doi: 10.1016/S2213-2600(15)00139-3. Epub 2015 Apr 27.
10
Characteristics of Critically Ill Infants at the End of Life in the Neonatal Intensive Care Unit.危重新生儿生命终末期在新生儿重症监护病房的特征。
J Palliat Med. 2023 May;26(5):674-683. doi: 10.1089/jpm.2022.0408. Epub 2022 Dec 8.

引用本文的文献

1
Transforming NICU care: rapid WES and transcriptomics-validation, social impact, and cost analysis.变革新生儿重症监护病房护理:快速全外显子测序和转录组学验证、社会影响及成本分析
Eur J Pediatr. 2025 Jun 27;184(7):453. doi: 10.1007/s00431-025-06225-2.
2
Benefits and barriers to broad implementation of genomic sequencing in the NICU.新生儿重症监护病房广泛开展基因组测序的益处与障碍。
Am J Hum Genet. 2025 Jun 5;112(6):1270-1285. doi: 10.1016/j.ajhg.2025.04.007. Epub 2025 May 13.
3
Health-related quality of life in patients with diverse rare diseases: An online survey.

本文引用的文献

1
Use of Exome Sequencing for Infants in Intensive Care Units: Ascertainment of Severe Single-Gene Disorders and Effect on Medical Management.在重症监护病房对婴儿使用外显子组测序:严重单基因疾病的确诊及对医疗管理的影响
JAMA Pediatr. 2017 Dec 4;171(12):e173438. doi: 10.1001/jamapediatrics.2017.3438.
2
Diagnostic Impact and Cost-effectiveness of Whole-Exome Sequencing for Ambulant Children With Suspected Monogenic Conditions.全外显子组测序对疑似单基因疾病的门诊儿童的诊断影响及成本效益
JAMA Pediatr. 2017 Sep 1;171(9):855-862. doi: 10.1001/jamapediatrics.2017.1755.
3
Benchmarking outcomes in the Neonatal Intensive Care Unit: Cytogenetic and molecular diagnostic rates in a retrospective cohort.
不同罕见病患者的健康相关生活质量:一项在线调查。
Genet Med Open. 2024 Aug 15;2:101889. doi: 10.1016/j.gimo.2024.101889. eCollection 2024.
4
The application of whole-exome sequencing in the early diagnosis of rare genetic diseases in children: a study from Southeastern China.全外显子测序在儿童罕见遗传病早期诊断中的应用:来自中国东南部的一项研究。
Front Pediatr. 2024 Oct 8;12:1448895. doi: 10.3389/fped.2024.1448895. eCollection 2024.
5
Implementation of rapid genomic sequencing in safety-net neonatal intensive care units: protocol for the VIrtual GenOme CenteR (VIGOR) proof-of-concept study.安全网新生儿重症监护病房快速基因组测序的实施:虚拟基因组中心(VIGOR)概念验证研究的方案。
BMJ Open. 2024 Feb 6;14(2):e080529. doi: 10.1136/bmjopen-2023-080529.
6
Diagnostic delay in monogenic disease: A scoping review.单基因疾病的诊断延迟:范围综述。
Genet Med. 2024 Apr;26(4):101074. doi: 10.1016/j.gim.2024.101074. Epub 2024 Jan 17.
7
Applications of advanced technologies for detecting genomic structural variation.先进技术在检测基因组结构变异中的应用。
Mutat Res Rev Mutat Res. 2023 Jul-Dec;792:108475. doi: 10.1016/j.mrrev.2023.108475. Epub 2023 Nov 4.
8
Parents' Perspectives on the Utility of Genomic Sequencing in the Neonatal Intensive Care Unit.父母对新生儿重症监护病房中基因组测序效用的看法。
J Pers Med. 2023 Jun 21;13(7):1026. doi: 10.3390/jpm13071026.
9
The fundamental need for unifying phenotypes in sudden unexpected pediatric deaths.统一小儿意外猝死表型的根本需求。
Front Med (Lausanne). 2023 Jun 2;10:1166188. doi: 10.3389/fmed.2023.1166188. eCollection 2023.
10
Rapid exome sequencing as a first-tier test in neonates with suspected genetic disorder: results of a prospective multicenter clinical utility study in the Netherlands.快速外显子测序作为疑似遗传疾病新生儿的一线检测手段:荷兰一项前瞻性多中心临床实用性研究的结果。
Eur J Pediatr. 2023 Jun;182(6):2683-2692. doi: 10.1007/s00431-023-04909-1. Epub 2023 Mar 31.
新生儿重症监护病房的结果基准:一项回顾性队列研究中的细胞遗传学和分子诊断率
Am J Med Genet A. 2017 Jul;173(7):1839-1847. doi: 10.1002/ajmg.a.38250. Epub 2017 May 9.
4
Characterization of a novel mutation in a pediatric case of septo-optic dysplasia.一名小儿视隔发育不良病例中一种新突变的特征分析。
Clin Case Rep. 2017 Mar 2;5(4):463-470. doi: 10.1002/ccr3.868. eCollection 2017 Apr.
5
Prospective comparison of the cost-effectiveness of clinical whole-exome sequencing with that of usual care overwhelmingly supports early use and reimbursement.临床全外显子组测序与常规护理的成本效益的前瞻性比较压倒性地支持早期使用和报销。
Genet Med. 2017 Aug;19(8):867-874. doi: 10.1038/gim.2016.221. Epub 2017 Jan 26.
6
What happens when N = 1 and you want plus 1?当N = 1且你想要加1时会发生什么?
Prenat Diagn. 2017 Jan;37(1):70-72. doi: 10.1002/pd.4975. Epub 2016 Dec 30.
7
Next-generation sequencing for diagnosis of rare diseases in the neonatal intensive care unit.用于新生儿重症监护病房罕见病诊断的下一代测序技术。
CMAJ. 2016 Aug 9;188(11):E254-E260. doi: 10.1503/cmaj.150823. Epub 2016 May 30.
8
A prospective evaluation of whole-exome sequencing as a first-tier molecular test in infants with suspected monogenic disorders.对全外显子组测序作为疑似单基因疾病婴儿的一线分子检测的前瞻性评估。
Genet Med. 2016 Nov;18(11):1090-1096. doi: 10.1038/gim.2016.1. Epub 2016 Mar 3.
9
Whole-Exome Sequencing and Whole-Genome Sequencing in Critically Ill Neonates Suspected to Have Single-Gene Disorders.对疑似患有单基因疾病的危重新生儿进行全外显子组测序和全基因组测序。
Cold Spring Harb Perspect Med. 2015 Dec 18;6(2):a023168. doi: 10.1101/cshperspect.a023168.
10
Rapid whole genome sequencing and precision neonatology.快速全基因组测序与精准新生儿学。
Semin Perinatol. 2015 Dec;39(8):623-31. doi: 10.1053/j.semperi.2015.09.009. Epub 2015 Oct 29.